Cargando…
Subtyping based on immune cell fractions reveal heterogeneity of cardiac fibrosis in end-stage heart failure
BACKGROUND: A central issue hindering the development of effective anti-fibrosis drugs for heart failure is the unclear interrelationship between fibrosis and the immune cells. This study aims at providing precise subtyping of heart failure based on immune cell fractions, elaborating their differenc...
Autores principales: | Zou, Shangjie, Khoo, Bee Luan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975711/ https://www.ncbi.nlm.nih.gov/pubmed/36875078 http://dx.doi.org/10.3389/fimmu.2023.1053793 |
Ejemplares similares
-
A 6-gene panel as a signature to predict recovery from advanced heart failure using transcriptomic analysis
por: Zou, Shangjie, et al.
Publicado: (2022) -
A deformability-based biochip for precise label-free stratification of metastatic subtypes using deep learning
por: Hua, Haojun, et al.
Publicado: (2023) -
Label-free enrichment of human blast cells from whole blood for leukemia monitoring
por: Fu, Yatian, et al.
Publicado: (2022) -
Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure
por: Cavalli, Giulio, et al.
Publicado: (2017) -
Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
por: Sweeney, Mark, et al.
Publicado: (2020)